December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Derek Lynch: What an honor it was to moderate this conversation between two incredible childhood cancer survivors
Mar 12, 2024, 20:51

Derek Lynch: What an honor it was to moderate this conversation between two incredible childhood cancer survivors

Derek Lynch, Pediatric Resource Specialist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, shared a post by Oncoheroes Biosciences on LinkedIn, adding:

“What an honor it was to moderate this conversation between two incredible childhood cancer survivors. Richi and Albert – thank you so much for sharing your stories, and thank you Oncoheroes Biosciences and Richi Childhood Cancer Foundation for the opportunity!”

Quoting Oncoheroes Biosciences’ post:

“How do you live a cancer diagnosis as a child? How is life after treatment? Albert Ananyan and Richi Garcia Puig, two young childhood cancer survivors shared their experiences with cancer at the Oncothon2024 by OncoDaily.

In a session led by Derek Lynch, volunteer at the Richi Childhood Cancer Foundation, Albert and Richi bravely recounted the treatments they endured and the profound impact childhood cancer had on their lives. Despite the adversity they faced, both are now pursuing their dreams with passion and determination.

Albert, reflecting on his journey, shared, “life is full of challenges, but that’s its beauty.” His words encapsulate the spirit of resilience that has driven him forward. Richi, on the brink of his junior year at Framingham University, offered inspiring advice to fellow survivors, urging them to embrace their dreams and live life to the fullest. “Find your passion and pursue it relentlessly,” he emphasized.

For those seeking further insight into their compelling stories, the full session can be accessed through the link below. Don’t miss out, and remember to subscribe, as more captivating sessions from the series will be shared soon”.

Additional information.
Source: Derek Lynch/LinkedIn and Oncoheroes Biosciences/LinkedIn